Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Toviaz (Registered)

NCT00879398 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00879398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Toviaz (Registered)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
August 31, 2014
Enrollment
3,000 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder